<unk>  is a medium-to-long acting sulfonylurea anti-diabetic drug. It is marketed as Amaryl by Sanofi-Aventis.<unk>  is the first third-generation sulfonylurea, and is very potent.
Glimepiride detailed information
Rosiglitazone detailed information
Donepezil detailed information
Dextropropoxyphene detailed information
Diabetes dietary recommendations of american diabetes association
Metoprolol detailed information
Hirsutism cost-effectiveness of therapy
Insulinoma future or investigational therapies